Alteration of protein function by a silent polymorphism linked to tRNA abundance

PLoS Biology

Volumn 15, Issue 5, 2017, Pages

  Kirchner, Sebastian ^a,f   Cai, Zhiwei ^b   Rauscher, Robert ^c   Kastelic, Nicolai ^a   Anding, Melanie ^a   Czech, Andreas ^c   Kleizen, Bertrand ^d   Ostedgaard, Lynda S ^e   Braakman, Ineke ^d   Sheppard, David N ^b   Ignatova, Zoya ^a,c  

^a UNIVERSITY OF POTSDAM   (Germany)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c UNIVERSITY OF HAMBURG   (Germany)

^d UTRECHT UNIVERSITY   (Netherlands)

^e UNIVERSITY OF IOWA   (United States)

^f UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; TRANSFER RNA;

ARTICLE; BRONCHIAL EPITHELIAL CELL; CODON; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; EPITHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; PROTEIN CONFORMATION; PROTEIN FUNCTION; PROTEIN STABILITY; RNA TRANSLATION; SINGLE NUCLEOTIDE POLYMORPHISM; STEADY STATE; THERMOSTABILITY; UPREGULATION; GENETICS; HEK293 CELL LINE; HELA CELL LINE; METABOLISM; SILENT MUTATION; STRUCTURE ACTIVITY RELATION;

CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; HEK293 CELLS; HELA CELLS; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN STABILITY; RNA, TRANSFER; SILENT MUTATION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 85020168824     PISSN: 15449173     EISSN: 15457885     Source Type: Journal    
DOI: 10.1371/journal.pbio.2000779     Document Type: Article

References (73)

1. ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature. 2012;489: 57–74. doi: 10.1038/nature11247 22955616
2. Boyko AR, Williamson SH, Indap AR, Degenhardt JD, Hernandez RD, Lohmueller KE, et al. Assessing the evolutionary impact of amino acid mutations in the human genome. PLoS Genet. 2008;4: e1000083. doi: 10.1371/journal.pgen.1000083 18516229
3. Chamary JV, Parmley JL, Hurst LD, Hearing silence: non-neutral evolution at synonymous sites in mammals. Nat Rev Genet. 2006;7: 98–108. doi: 10.1038/nrg1770 16418745
4. Xu Y, Ma P, Shah P, Rokas A, Liu Y, Johnson CH, Non-optimal codon usage is a mechanism to achieve circadian clock conditionality. Nature. 2013;495: 116–20. doi: 10.1038/nature11942 23417065
5. Zhou M, Guo J, Cha J, Chae M, Chen S, Barral JM, et al. Non-optimal codon usage affects expression, structure and function of clock protein FRQ. Nature. 2013;495: 111–5. doi: 10.1038/nature11833 23417067
6. Jacobson GN, Clark PL, Quality over quantity: optimizing co-translational protein folding with non-'optimal' synonymous codons. Curr Opin Struct Biol. 2016;38: 102–10. doi: 10.1016/j.sbi.2016.06.002 27318814
7. Koutmou KS, Radhakrishnan A, Green R, Synthesis at the speed of codons. Trends Biochem Sci. 2015;40: 717–8. doi: 10.1016/j.tibs.2015.10.005 26526516
8. Richter JD, Coller J, Pausing on polyribosomes: make way for elongation in translational control. Cell. 2015;163: 292–300. doi: 10.1016/j.cell.2015.09.041 26451481
9. Nackley AG, Shabalina SA, Tchivileva IE, Satterfield K, Korchynskyi O, Makarov SS, et al. Human catechol-O-methyltransferase haplotypes modulate protein expression by altering mRNA secondary structure. Science. 2006;314: 1930–3. doi: 10.1126/science.1131262 17185601
10. Sauna ZE, Kimchi-Sarfaty C, Understanding the contribution of synonymous mutations to human disease. Nat Rev Genet. 2011;12: 683–91. doi: 10.1038/nrg3051 21878961
11. Coleman JR, Papamichail D, Skiena S, Futcher B, Wimmer E, Mueller S, Virus attenuation by genome-scale changes in codon pair bias. Science. 2008;320: 1784–7. doi: 10.1126/science.1155761 18583614
12. Kimchi-Sarfaty C, Oh JM, Kim IW, Sauna ZE, Calcagno AM, Ambudkar SV, et al. A "silent" polymorphism in the MDR1 gene changes substrate specificity. Science. 2007;315: 525–8. doi: 10.1126/science.1135308 17185560
13. Yu CH, Dang Y, Zhou Z, Wu C, Zhao F, Sachs MS, et al. Codon usage influences the local rate of translation elongation to regulate co-translational protein folding. Mol Cell. 2015;59: 744–54. doi: 10.1016/j.molcel.2015.07.018 26321254
14. Guo H, Ingolia NT, Weissman JS, Bartel DP, Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature. 2010;466: 835–40. doi: 10.1038/nature09267 20703300
15. Pop C, Rouskin S, Ingolia NT, Han L, Phizicky EM, Weissman JS, et al. Causal signals between codon bias, mRNA structure, and the efficiency of translation and elongation. Mol Syst Biol. 2014;10: 770. doi: 10.15252/msb.20145524 25538139
16. Kirchner S, Ignatova Z, Emerging roles of tRNA in adaptive translation, signalling dynamics and disease. Nat Rev Genet. 2015;16: 98–112. doi: 10.1038/nrg3861 25534324
17. Fluitt A, Pienaar E, Viljoen H, Ribosome kinetics and aa-tRNA competition determine rate and fidelity of peptide synthesis. Comp Biol Chem. 2007;31: 335–46. doi: 10.1016/j.compbiolchem.2007.07.003 17897886
18. Plotkin JB, Kudla G, Synonymous but not the same: the causes and consequences of codon bias. Nat Rev Genet. 2011;12: 32–42. doi: 10.1038/nrg2899 21102527
19. Gingold H, Tehler D, Christoffersen NR, Nielsen MM, Asmar F, Kooistra SM, et al. A dual program for translation regulation in cellular proliferation and differentiation. Cell. 2014;158: 1281–92. doi: 10.1016/j.cell.2014.08.011 25215487
20. Dittmar KA, Goodenbour JM, Pan T, Tissue-specific differences in human transfer RNA expression. PLoS Genet. 2006;2: e221. doi: 10.1371/journal.pgen.0020221 17194224
21. Ishimura R, Nagy G, Dotu I, Zhou H, Yang XL, Schimmel P, et al. RNA function. Ribosome stalling induced by mutation of a CNS-specific tRNA causes neurodegeneration. Science. 2014;345: 455–9. doi: 10.1126/science.1249749 25061210
22. Gadsby DC, Vergani P, Csanady L, The ABC protein turned chloride channel whose failure causes cystic fibrosis. Nature. 2006;440: 477–83. doi: 10.1038/nature04712 16554808
23. Cutting GR, Cystic fibrosis genetics: from molecular understanding to clinical application. Nat Rev Genet. 2015;16: 45–56. doi: 10.1038/nrg3849 25404111
24. Veit G, Avramescu RG, Chiang AN, Houck SA, Cai Z, Peters KW, et al. From CFTR biology toward combinatorial pharmacotherapy: expanded classification of cystic fibrosis mutations. Mol Biol Cell. 2016;27: 424–33. doi: 10.1091/mbc.E14-04-0935 26823392
25. Cheng SH, Gregory RJ, Marshall J, Paul S, Souza DW, White GA, et al. Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell. 1990;63: 827–34. 1699669
26. Steiner B, Truninger K, Sanz J, Schaller A, Gallati S, The role of common single-nucleotide polymorphisms on exon 9 and exon 12 skipping in nonmutated CFTR alleles. Human Mutat. 2004;24: 120–9. doi: 10.1002/humu.20064 15241793
27. Aissat A, de Becdelievre A, Golmard L, Vasseur C, Costa C, Chaoui A, et al. Combined computational-experimental analyses of CFTR exon strength uncover predictability of exon-skipping level. Human Mutat. 2013;34: 873–81. doi: 10.1002/humu.22300 23420618
28. Masvidal L, Igreja S, Ramos MD, Alvarez A, de Gracia J, Ramalho A, et al. Assessing the residual CFTR gene expression in human nasal epithelium cells bearing CFTR splicing mutations causing cystic fibrosis. Eur J Human Genet. 2014;22: 784–91. doi: 10.1038/ejhg.2013.238 24129438
29. Vecchio-Pagan B, Blackman SM, Lee M, Atalar M, Pellicore MJ, Pace RG, et al. Deep resequencing of CFTR in 762 F508del homozygotes reveals clusters of non-coding variants associated with cystic fibrosis disease traits. Hum Genome Variat. 2016;3: 16038. doi: 10.1038/hgv.2016.38 27917292
30. Okiyoneda T, Barriere H, Bagdany M, Rabeh WM, Du K, Hohfeld J, et al. Peripheral protein quality control removes unfolded CFTR from the plasma membrane. Science. 2010;329: 805–10. doi: 10.1126/science.1191542 20595578
31. Younger JM, Chen L, Ren HY, Rosser MF, Turnbull EL, Fan CY, et al. Sequential quality-control checkpoints triage misfolded cystic fibrosis transmembrane conductance regulator. Cell. 2006;126: 571–82. doi: 10.1016/j.cell.2006.06.041 16901789
32. Sharma M, Benharouga M, Hu W, Lukacs GL, Conformational and temperature-sensitive stability defects of the ΔF508 cystic fibrosis transmembrane conductance regulator in post-endoplasmic reticulum compartments. J Biol Chem. 2001;276: 8942–50. doi: 10.1074/jbc.M009172200 11124952
33. Sheppard DN, Welsh MJ, Structure and function of the CFTR chloride channel. Physiol Rev. 1999;79: S23–45. 9922375
34. Scott-Ward TS, Cai Z, Dawson ES, Doherty A, Da Paula AC, Davidson H, et al. Chimeric constructs endow the human CFTR Cl- channel with the gating behavior of murine CFTR. Proc Natl Acad Sci USA. 2007;104: 16365–70. doi: 10.1073/pnas.0701562104 17913891
35. Krouse ME, Schneider GT, Gage PW, A large anion-selective channel has seven conductance levels. Nature. 1986;319: 58–60. doi: 10.1038/319058a0 2417122
36. Ionescu L, White C, Cheung KH, Shuai J, Parker I, Pearson JE, et al. Mode switching is the major mechanism of ligand regulation of InsP3 receptor calcium release channels. J Gen Physiol. 2007;130: 631–45. doi: 10.1085/jgp.200709859 17998395
37. Jih KY, Sohma Y, Hwang TC, Nonintegral stoichiometry in CFTR gating revealed by a pore-lining mutation. J Gen Physiol. 2012;140: 347–59. doi: 10.1085/jgp.201210834 22966014
38. Krouse ME, Wine JJ, Evidence that CFTR channels can regulate the open duration of other CFTR channels: cooperativity. J Membr Biol. 2001;182: 223–32. 11547345
39. Ingolia NT, Ribosome profiling: new views of translation, from single codons to genome scale. Nat Rev Genet. 2014;15: 205–13. doi: 10.1038/nrg3645 24468696
40. Lareau LF, Hite DH, Hogan GJ, Brown PO, Distinct stages of the translation elongation cycle revealed by sequencing ribosome-protected mRNA fragments. eLife. 2014;3: e01257doi: 10.7554/eLife.01257 24842990
41. Buhr F, Jha S, Thommen M, Mittelstaet J, Kutz F, Schwalbe H, et al. Synonymous codons direct cotranslational folding toward different protein conformations. Mol Cell. 2016;61: 341–51. doi: 10.1016/j.molcel.2016.01.008 26849192
42. Sander IM, Chaney JL, Clark PL, Expanding Anfinsen's principle: contributions of synonymous codon selection to rational protein design. J Am Chem Soc. 2014;136: 858–61. doi: 10.1021/ja411302m 24392935
43. Zhang G, Hubalewska M, Ignatova Z, Transient ribosomal attenuation coordinates protein synthesis and co-translational folding. Nat Stuct Mol Biol. 2009;16: 274–80. doi: 10.1038/nsmb.1554 19198590
44. Bartoszewski RA, Jablonsky M, Bartoszewska S, Stevenson L, Dai Q, Kappes J, et al. A synonymous single nucleotide polymorphism in ΔF508 CFTR alters the secondary structure of the mRNA and the expression of the mutant protein. J Biol Chem. 2010;285: 28741–8. doi: 10.1074/jbc.M110.154575 20628052
45. Kleizen B, van Vlijmen T, de Jonge HR, Braakman I, Folding of CFTR is predominantly cotranslational. Mol Cell. 2005;20: 277–87. doi: 10.1016/j.molcel.2005.09.007 16246729
46. Kim SJ, Yoon JS, Shishido H, Yang Z, Rooney LA, Barral JM, et al. Protein folding. Translational tuning optimizes nascent protein folding in cells. Science. 2015;348: 444–8. doi: 10.1126/science.aaa3974 25908822
47. Du K, Lukacs GL, Cooperative assembly and misfolding of CFTR domains in vivo. Mol Biol Cell. 2009;20: 1903–15. doi: 10.1091/mbc.E08-09-0950 19176754
48. Mendoza JL, Schmidt A, Li Q, Nuvaga E, Barrett T, Bridges RJ, et al. Requirements for efficient correction of ΔF508 CFTR revealed by analyses of evolved sequences. Cell. 2012;148: 164–74. doi: 10.1016/j.cell.2011.11.023 22265409
49. Rabeh WM, Bossard F, Xu H, Okiyoneda T, Bagdany M, Mulvihill CM, et al. Correction of both NBD1 energetics and domain interface is required to restore ΔF508 CFTR folding and function. Cell. 2012;148: 150–63. doi: 10.1016/j.cell.2011.11.024 22265408
50. Thibodeau PH, Richardson JM, 3rdWang W, Millen L, Watson J, Mendoza JL, et al. The cystic fibrosis-causing mutation ΔF508 affects multiple steps in cystic fibrosis transmembrane conductance regulator biogenesis. J Biol Chem. 2010;285: 35825–35. doi: 10.1074/jbc.M110.131623 20667826
51. Fu J, Ji HL, Naren AP, Kirk KL, A cluster of negative charges at the amino terminal tail of CFTR regulates ATP-dependent channel gating. J Physiol. 2001;536: 459–70. doi: 10.1111/j.1469-7793.2001.0459c.xd 11600681
52. Zhang Z, Chen J, Atomic structure of the cystic fibrosis transmembrane conductance regulator. Cell. 2016;167: 1586–97. doi: 10.1016/j.cell.2016.11.014 27912062
53. Bozoky Z, Krzeminski M, Chong PA, Forman-Kay JD, Structural changes of CFTR R region upon phosphorylation: a plastic platform for intramolecular and intermolecular interactions. FEBS J. 2013;280: 4407–16. doi: 10.1111/febs.12422 23826884
54. Liang X, Da Paula AC, Bozoky Z, Zhang H, Bertrand CA, Peters KW, et al. Phosphorylation-dependent 14-3-3 protein interactions regulate CFTR biogenesis. Mol Biol Cell. 2012;23: 996–1009. doi: 10.1091/mbc.E11-08-0662 22278744
55. Drumm ML, Ziady AG, Davis PB, Genetic variation and clinical heterogeneity in cystic fibrosis. Annu Rev Pathol. 2012;7: 267–82. doi: 10.1146/annurev-pathol-011811-120900 22017581
56. Cuppens H, Marynen P, De Boeck C, Cassiman JJ, Detection of 98.5% of the mutations in 200 Belgian cystic fibrosis alleles by reverse dot-blot and sequencing of the complete coding region and exon/intron junctions of the CFTR gene. Genomics. 1993;18: 693–7. 7508414
57. Rosendahl J, Landt O, Bernadova J, Kovacs P, Teich N, Bodeker H, et al. CFTR, SPINK1, CTRC and PRSS1 variants in chronic pancreatitis: is the role of mutated CFTR overestimated?Gut. 2013;62: 582–92. doi: 10.1136/gutjnl-2011-300645 22427236
58. Bombieri C, Claustres M, De Boeck K, Derichs N, Dodge J, Girodon E, et al. Recommendations for the classification of diseases as CFTR-related disorders. J Cyst Fibr. 2011;10Suppl 2: S86–102.
59. de Cid R, Ramos MD, Aparisi L, Garcia C, Mora J, Estivill X, et al. Independent contribution of common CFTR variants to chronic pancreatitis. Pancreas. 2010; 39: 209–15. doi: 10.1097/MPA.0b013e3181bab679 19812525
60. Tzetis M, Efthymiadou A, Strofalis S, Psychou P, Dimakou A, Pouliou E, et al. CFTR gene mutations—including three novel nucleotide substitutions—and haplotype background in patients with asthma, disseminated bronchiectasis and chronic obstructive pulmonary disease. Human Genet. 2001;108: 216–21. 11354633
61. Bali V, Lazrak A, Guroji P, Fu L, Matalon S, Bebok Z, A synonymous codon change alters the drug sensitivity of ΔF508 cystic fibrosis transmembrane conductance regulator. FASEB J. 2016;30: 201–13. doi: 10.1096/fj.15-273714 26336913
62. Shah K, Cheng Y, Hahn B, Bridges R, Bradbury NA, Mueller DM, Synonymous codon usage affects the expression of wild type and F508del CFTR. J Mol Biol. 2015;427: 1464–79. doi: 10.1016/j.jmb.2015.02.003 25676312
63. Veit G, Oliver K, Apaja PM, Perdomo D, Bidaud-Meynard A, Lin ST, et al. Ribosomal stalk protein silencing partially corrects the ΔF508-CFTR functional expression defect. PLoS Biol. 2016;14(5): e1002462. doi: 10.1371/journal.pbio.1002462 27168400
64. Cai Z, Palmai-Pallag T, Khuituan P, Mutolo MJ, Boinot C, Liu B, et al. Impact of the F508del mutation on ovine CFTR, a Cl- channel with enhanced conductance and ATP-dependent gating. J Physiol. 2015;593: 2427–46. doi: 10.1113/JP270227 25763566
65. Kirchner S, Rauscher R, Czech A, Ignatova Z. Upregulating tRNAs in mammalian cells through transfection of in vitro transcribed tRNAs. Protocols.io. 2017. doi: 10.17504/protocols.io.hetb3en
66. Cai Z, Taddei A, Sheppard DN, Differential sensitivity of the cystic fibrosis (CF)-associated mutants G551D and G1349D to potentiators of the cystic fibrosis transmembrane conductance regulator (CFTR) Cl- channel. J Biol Chem. 2006;281: 1970–7. doi: 10.1074/jbc.M510576200 16311240
67. Manivannan K, Ramanan SV, Mathias RT, Brink PR, Multichannel recordings from membranes which contain gap junctions. Biophys J. 1992;61: 216–27. doi: 10.1016/S0006-3495(92)81828-3 1371704
68. Kirchner S, Rauscher R, Czech A, Ignatova Z. Microarray-based quantification of cellular tRNAs. Protocols.io. 2017. doi: 10.17504/protocols.io.hfcb3iw
69. Gerber AP, Keller W, An adenosine deaminase that generates inosine at the wobble position of tRNAs. Science. 1999;286: 1146–9. 10550050
70. Kirchner S, Rauscher R, Czech A, Ignatova Z. tRNA Knock-down in mammalian cells using short hairpin RNAs. Protocols.io. 2017. doi: 10.17504/protocols.io.hgfb3tn
71. Mohammad F, Woolstenhulme CJ, Green R, Buskirk AR, Clarifying the translational pausing landscape in bacteria by ribosome profiling. Cell Rep. 2016;14: 686–94. doi: 10.1016/j.celrep.2015.12.073 26776510
72. Mornon JP, Lehn P, Callebaut I, Molecular models of the open and closed states of the whole human CFTR protein. Cell Mol Life Sci. 2009;66: 3469–86. doi: 10.1007/s00018-009-0133-0 19707853
73. Hinzpeter A, Aissat A, Sondo E, Costa C, Arous N, Gameiro C, et al. Alternative splicing at a NAGNAG acceptor site as a novel phenotype modifier. PLoS Genet. 2010;6:e1001153. doi: 10.1371/journal.pgen.1001153 20949073